多病共存患者治疗负担相关评估工具的研究进展

周珊; 李娜; 马力

doi:10.16766/j.cnki.issn.1674-4152.004012

多病共存患者治疗负担相关评估工具的研究进展

doi: 10.16766/j.cnki.issn.1674-4152.004012

周珊^{1, 2},
李娜²,
马力^2, ,

1.
首都医科大学全科医学与继续教育学院，北京 100069
2.
首都医科大学附属北京天坛医院全科医疗科，北京 100070

基金项目:

2022年度首都全科医学研究专项 22QK13

高层次公共卫生技术人才建设项目学科带头人-02-09

详细信息

通讯作者:
马力, E-mail: malittyy@126.com

中图分类号: R592
计量
- 文章访问数: 8
- HTML全文浏览量: 4
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2024-07-12
- 网络出版日期: 2025-08-14

Recent advances in tools for assessing the treatment burden of multimorbidity

ZHOU Shan^{1, 2},
LI Na²,
MA Li^{2
, ,}

1.
School of Practice and Continuing Education, Capital Medical University, Beijing 100069, China

摘要

摘要: 随着老龄化进程加快，慢性非传染性疾病患病率逐年增加，多病共存现象越来越普遍。多病共存患者的健康管理是全球卫生保健服务的重要挑战。相较于健康、患单一慢性病的人群，多病共存患者依赖更多的医疗资源，在影响个体生活质量的同时, 给家庭及社会带来沉重的照护压力和经济负担，加重治疗负担。治疗负担是指患者因为医疗保健需承担的工作及其带来的影响。患者会经历不同程度的治疗负担，了解治疗负担，识别并确定最有可能承受高治疗负担的人群，设计满足他们需求的医疗保健服务非常重要。美国、法国、英国等西方发达国家对治疗负担已有相关评估工具并得到推广应用，准确、有效评估治疗负担的工具有利于患者知晓自身健康状况及相应的挑战，为制定个性化干预措施、评价干预效果提供依据，积极的医学干预对减轻患者治疗负担有显著的积极作用。本文就多病共存患者治疗负担相关的评估工具进行总结，介绍了治疗负担的概念，治疗负担问卷、多病共存感知量表、日常用药负担问卷、医疗保健任务困难量表、患者关于治疗和自我管理的体验量表、药物负担相关的生活质量量表、慢性病共存治疗负担问卷、老年慢病共存患者治疗负担量表等主要评估工具的内容、信效度、优缺点，以期总结现有的经验和模式, 因地制宜创新适宜本土文化的多病共存患者治疗负担的评估工具, 为医务人员选择相关评估工具提供参考。
- 多病共存 /
- 治疗负担 /
- 评估工具
Abstract: With the acceleration of aging, the prevalence of chronic noncommunicable diseases and multimorbidity is increasing, posing significant challenges for patients health management. Compared with healthy individuals or those with a single chronic disease, patients with multimorbidity need more medical resources, which affects their quality of life and places a heavy healthcare and economic burden on families and society. The treatment burden refers to the physical, emotional, and logistical demands patients undertake due to their healthcare needs, with varying degrees of treatment burden across individuals. It is important to identify the populations at the highest risk of significant treatment burden for designing healthcare services that meet their needs. Countries such as the United States, France, and the United Kingdom have developed assessment tools for treatment burden. Accurate and effective assessment tools are essential for helping patients understand their health status and challenges, providing a basis for personalized interventions and outcome evaluation. Active medical interventions have been significantly reduced treatment burden. It summarizes the assessment tools for treatment burden on patients with multimorbidity, detailing their contents, reliability, validity, advantages, and disadvantages. Key tools discussed include the treatment burden questionnaire, multimorbidity illness perceptions scale, living with medicines questionnaire, health care task difficulty, patient experience with treatment and self-management, medication-related burden quality of life, and the multimorbidity treatment burden questionnaire. The goal is to summarize the existing experience and models, innovate culturally appropriate assessment tools, and provide reference for healthcare professionals in selecting the relevant assessment tool.
- Multimorbidity /
- Treatment burden /
- Assessment tools

HTML全文

参考文献(43)

[1]	唐天娇, 曹立, 董碧蓉, 等. 老年人多病共存名词和定义专家共识(2022)[J]. 中华老年医学杂志, 2022, 41(9): 1028-1031. doi: 10.3760/cma.j.issn.0254-9026.2022.09.002 TANG T J, CAO L, DONG B R, et al. Chinese expert consensus on the term and definition of multimorbidity in older adults(2022)[J]. Chinese Journal of Geriatrics, 2022, 41(9): 1028-1031. doi: 10.3760/cma.j.issn.0254-9026.2022.09.002
[2]	ZHOU Y, DAI X, NI Y, et al. Interventions and management on multimorbidity: an overview of systematic reviews[J]. Ageing Res Rev, 2023, 87: 101901. DOI: 10.1016/j.arr.2023.101901.
[3]	HOUNKPATIN H O, RODERICK P, MORRIS J E, et al. Change in treatment burden among people with multimorbidity: protocol of a follow up survey and development of efficient measurement tools for primary care[J]. PLoS One, 2021, 16(11): e0260228. DOI: 10.1371/journal.pone.0260228.
[4]	HARDMAN R, BEGG S, SPELTEN E. Exploring the ability of self-report measures to identify risk of high treatment burden in chronic disease patients: a cross-sectional study[J]. BMC Public Health, 2022, 22(1): 163. DOI: 10.1186/s12889-022-12579-1.
[5]	马梦琪, 彭芳, 江雪萌, 等. 慢性心力衰竭病人治疗负担研究进展[J]. 护理研究, 2023, 37(10): 1760-1764. doi: 10.12102/j.issn.1009-6493.2023.10.013 MA M Q, PENG F, JIANG X M, et al. Research progress on treatment burden of patients with chronic heart failure[J]. Chinese Nursing Research, 2023, 37(10): 1760-1764. doi: 10.12102/j.issn.1009-6493.2023.10.013
[6]	ALTABEE R, CARR S B, ABBOTT J, et al. Exploring the nature of perceived treatment burden: a study to compare treatment burden measures in adults with cystic fibrosis[J]. NIHR Open Res, 2022, 2: 36. DOI: 10.1186/s12889-022-12579-1.
[7]	秉岩. 社区中老年糖尿病共病患者的治疗负担水平及影响因素研究[D]. 上海: 中国人民解放军海军军医大学, 2023. BING Y. Study on treatment burden and influencing factors of middle-aged and elderly patients with diabetes comorbidities in community[D]. Shanghai: The Second Military Medical University, 2023.
[8]	TRAN V T, MONTORI V M, ETON D T, et al. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions[J]. BMC Med, 2012, 10(1): 68. DOI: 10.1186/1741-7015-10-68.
[9]	TRAN V T, HARRINGTON M, MONTORI V M, et al. Adaptation and validation of the treatment burden questionnaire (TBQ) in English using an internet platform[J]. BMC Med, 2014, 12(1): 109. DOI: 10.1186/1741-7015-12-109.
[10]	YSRRAELIT M C, FIOL M P, PEÑA F V, et al. Adaptation and validation of a Spanish version of the treatment burden questionnaire in patients with multiple sclerosis[J]. BMC Neurol, 2019, 19(1): 209. DOI: 10.1186/s12883-019-1441-0.
[11]	CHIN W Y, WONG C K H, NG C C W, et al. Cultural adaptation and psychometric properties of the Chinese burden of treatment questionnaire (C-TBQ) in primary care patients with multi-morbidity[J]. Fam Pract, 2019, 36(5): 657-665.
[12]	郭丽红. TBQ(治疗负担问卷)的汉化及初步应用探索[D]. 汕头: 汕头大学, 2021. GUO L H. TBQ(Treatment Burden Questionnaire) Chineseization and preliminary application exploration[D]. Shantou: Shantou University, 2021.
[13]	林恺, 郭丽红, 黄周红, 等. 简体中文版慢性病TBQ汉化及信效度研究[J]. 中华全科医学, 2022, 20(6): 974-977, 1011. doi: 10.16766/j.cnki.issn.1674-4152.002502 LIN K, GUO L H, HUANG Z H, et al. Sinicization, reliability and validity of the simplified Chinese Treatment Burden Questionnaire for chronic disease[J]. Chinese Journal of General Practice, 2022, 20(6): 974-977, 1011. doi: 10.16766/j.cnki.issn.1674-4152.002502
[14]	GIBBONS C J, KENNING C, COVENTRY P A, et al. Development of a multimorbidity illness perceptions scale (MULTIPleS)[J]. PLoS One, 2013, 8(12): e81852. DOI: 10.1371/journal.pone.0081852.
[15]	MEJÍAS-TRUEBA M, FERNÁNDEZ-RUBIO B, LÓPEZ-HERMOSO C, et al. Traducción y adaptación transcultural al español de la escala MULTIPleS en pacientes de edad avanzada con multimorbilidad[J]. Medicina Clínica, 2022, 159(7): 327-329.
[16]	KRSKA J, MORECROFT C W, POOLE H, et al. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study[J]. Int J Clin Pharm, 2013, 35(6): 1161-1169.
[17]	KRSKA J, KATUSIIME B, CORLETT S. Validation of an instrument to measure patients’ experiences of medicine use: the living with medicines questionnaire[J]. Patient Prefer Adherence, 2017, 11: 671-679.
[18]	KATUSIIME B, CORLETT S, KRSKA J. Development and validation of a revised instrument to measure burden of long-term medicines use: the living with medicines questionnaire version 3[J]. Patient Relat Outcome Meas, 2018, 9: 155-168.
[19]	ZIDAN A, AWAISU A, HASAN S, et al. The living with medicines questionnaire: translation and cultural adaptation into the arabic context[J]. Value Health Reg Issues, 2016, 10: 36-40.
[20]	WANG Y, KRSKA J, LIN B, et al. Cross-cultural adaptation and reliability testing of Chinese version of the living with medicines questionnaire in elderly patients with chronic diseases[J]. Patient Prefer Adherence, 2020, 14: 2477-2487.
[21]	AWAD A, ALHADAB A, ALBASSAM A. Medication-related burden and medication adherence among geriatric patients in Kuwait: a cross-sectional study[J]. Front Pharmacol, 2020, 11: 1296. DOI: 10.3389/fphar.2020.01296.
[22]	TORDOFF J M, BRENKLEY C, KRSKA J, et al. Exploring medicines burden among adults in New Zealand: a cross-sectional survey[J]. Patient Prefer Adherence, 2019, 13: 2171-2184.
[23]	BEKALU A F, YENIT M K, TEKILE M T, et al. Medication-related burden and associated factors among diabetes mellitus patients at Felege Hiwot Comprehensive Specialized Hospital in northwest Ethiopia[J]. Front Clin Diabetes Healthc, 2022, 3: 977216. DOI: 10.3389/fcdhc.2022.977216.
[24]	BOYD C M, WOLFF J L, GIOVANNETTI E, et al. Healthcare task difficulty among older adults with multimorbidity[J]. Med Care, 2014, 52(3): S118-S125.
[25]	FERNÁNDEZ-RUBIO B, MEJÍAS-TRUEBA M, RODRÍGUEZ-PÉREZ A, et al. Transcultural translation and adaptation into Spanish of the questionnaire "Healthcare task difficulty (HCTD) among older-adults with multimorbidity"[J]. Rev Esp Salud Publica, 2021, 95: e202110167. PMID: 34620821.
[26]	ETON D T, YOST K J, LAI J S, et al. Development and validation of the patient experience with treatment and self-management (PETS): a patient-reported measure of treatment burden[J]. Qual Life Res, 2017, 26(2): 489-503.
[27]	ETON D, RIDGEWAY J, EGGINTON J, et al. Finalizing a measurement framework for the burden of treatment in complex patients with chronic conditions[J]. Patient Relat Outcome Meas, 2015, 6: 117-126.
[28]	HUSEBØ A M L, MORKEN I M, ERIKSEN K S, et al. The patient experience with treatment and self-management (PETS) questionnaire: translation and cultural adaption of the Norwegian version[J]. BMC Med Res Methodol, 2018, 18(1): 147. DOI: 10.1186/s12874-018-0612-9.
[29]	LEE M K, ST SAUVER J L, ANDERSON R T, et al. Confirmatory factor analyses and differential item functioning of the patient experience with treatment and self-management (PETS vs. 2.0): a measure of treatment burden[J]. Patient Relat Outcome Meas, 2021, 11: 249-263.
[30]	KOROS H, NOLTE E, KAMANO J, et al. Understanding the treatment burden of people with chronic conditions in Kenya: a cross-sectional analysis using the patient experience with treatment and self-management (PETS) questionnaire[J]. PLOS Glob Public Health, 2023, 3(1): e0001407. DOI: 10.1371/journal.pgph.0001407.
[31]	WOOD K, SARDAR A, ETON D T, et al. Adaptation and content validation of a patient-reported measure of treatment burden for use in stroke survivors: the patient experience with treatment and self-management in stroke (PETS-stroke) measure[J]. Disabil Rehabil, 2023, 6: 1-10. DOI: 10.1080/09638288.2023.2241360.
[32]	MOHAMMED M A, MOLES R J, HILMER S N, et al. Development and validation of an instrument for measuring the burden of medicine on functioning and well-being: medication-related burden quality of life (MRB-QoL) tool[J]. BMJ Open, 2018, 8(1): e018880. DOI: 10.1136/bmjopen-2017-018880.
[33]	DUNCAN P, MURPHY M, MAN M S, et al. Development and validation of the multimorbidity treatment burden questionnaire (MTBQ)[J]. BMJ Open, 2020, 8(4): e019413. DOI: 10.1136/bmjopen-2017-019413.
[34]	GIOVANNETTI E R, WOLFF J L, XUE Q L, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults[J]. J Gen Intern Med, 2012, 27(1): 37-44.
[35]	ETON D T, RAMALHO DE OLIVEIRA D, EGGINTON J, et al. Building a measurement framework of burden of treatment in complex patients with chronic conditions: a qualitative study[J]. Patient Relat Outcome Meas, 2012, 3: 39-49.
[36]	FRIIS K, LASGAARD M, PEDERSEN M H, et al. Health literacy, multimorbidity, and patient-perceived treatment burden in individuals with cardiovascular disease. A Danish population-based study[J]. Patient Educ Couns, 2019, 102(10): 1932-1938.
[37]	DOU L, HUANG J, DUNCAN P, et al. Translation, cultural adaptation and validation of the Chinese multimorbidity treatment burden questionnaire (C-MTBQ): a study of older hospital patients[J]. Health Qual Life Outcomes, 2020, 18(1): 194. DOI: 10.1186/s12955-020-01395-z.
[38]	GUÉNETTE L, TURCOTTE V, BÉLANGER L, et al. Multimorbidity treatment burden questionnaire (MTBQ): translation, cultural adaptation, and validation in French-Canadian[J]. Can J Aging, 2023, 42(1): 126-134.
[39]	VASILIAUSKIENEĖ O, VASILIAUSKAS D, DUNCAN P, et al. Validation of the Lithuanian multimorbidity treatment burden questionnaire (MTBQ) and its association with primary care patient characteristics[J]. Eur J Gen Pract, 2023, 29(1): 2284257. DOI: 10.1080/13814788.2023.2284257.
[40]	SCHULZE J, BRECKNER A, DUNCAN P, et al. Adaptation and validation of a German version of the multimorbidity treatment burden questionnaire[J]. Health Qual Life Outcomes, 2022, 20(1): 90. DOI: 10.1186/s12955-022-01993-z.
[41]	ENGELS L W S, VAN MERODE T, HEIJMANS M, et al. Measurement of treatment burden in patients with multimorbidity in the Netherlands: translation and validation of the multimorbidity treatment burden questionnaire (NL-MTBQ)[J]. Fam Pract, 2023: cmad100. DOI: 10.1093/fampra/cmad100.
[42]	SAMORINHA C, SAIDAWI W, DUNCAN P, et al. Translation, cross-cultural adaptation and validation of the Arabic multimorbidity treatment burden questionnaire (MTBQ-A): a study of adults with multimorbidity[J]. Res Social Adm Pharm, 2024, 20(4): 411-418.
[43]	柏丁兮, 高静, 杨直, 等. 老年慢病共存患者治疗负担量表的研制[J]. 中国全科医学, 2023, 26(13): 1613-1620. BAI D X, GAO J, YANG Z, et al. Development of a Treatment Burden Scale for Elderly Patients with Coexisting Chronic Diseases[J]. Chinese General Practice, 2023, 26(13): 1613-1620.